Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | RXRA | P19793 | 2/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.31 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SSTR1 | P30872 | 4/20 | 0.31 |
| ▸ | SSTR2 | P30874 | 4/20 | 0.31 |
| ▸ | SSTR4 | P31391 | 4/20 | 0.31 |
| ▸ | SSTR5 | P35346 | 4/20 | 0.31 |
| ▸ | SSTR3 | P32745 | 3/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7331386 | 0.91 | ITGB3 (0.37) | MEN1KMT2AITGB3ITGA2BMAPT | |
| SCHEMBL9009310 | 0.91 | ITGB3 (0.37) | MEN1KMT2AITGB3ITGA2BMAPT | |
| SCHEMBL7326445 | 0.90 | ITGB3 (0.35) | RXRAITGB3ITGA2BDPP4 | |
| SCHEMBL7330277 | 0.90 | MEN1 (0.34) | MEN1KMT2ARXRAITGB3ITGA2B | |
| SCHEMBL7331609 | 0.90 | ITGB3 (0.33) | MEN1KMT2ARXRAITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL7320336 | 0.89 | MEN1 (0.42) | MEN1KMT2ARXRAITGB3ITGA2B | |
| SCHEMBL7326326 | 0.89 | MEN1 (0.33) | MEN1KMT2AITGB3ITGA2BSSTR1 | |
| SCHEMBL7332009 | 0.88 | MEN1 (0.33) | MEN1KMT2AITGB3ITGA2BMAPT | |
| SCHEMBL7319156 | 0.87 | MEN1 (0.33) | MEN1KMT2ARXRATP53 | |
| SCHEMBL7331412 | 0.86 | ITGB3 (0.32) | MEN1KMT2AITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5674863-A | BENZODIAZEPINEDIONE DERIVATIVE; FIBRINOGIN BINDING INHIBITOR | GENENTECH, INC. (US) | 1997-10-07 | — | — | US | disclosed |
| US-5674865-A | BENZODIAZEPINEDIONE DERIVATIVE; FIBRINOGIN BINDING INHIBITOR | GENENTECH, INC. (US) | 1997-10-07 | — | — | US | disclosed |
| US-5663166-A | ANTICOAGULANTS OF 1,4-BENZODIAZEPINE-2,5-DIONE AND 2-BENZOAZEPINE-1,4-DIONE DERIVATIVES; PREVENTS FIBRINOGEN BINDING NECESSARY FOR PLATELET AGGREGATION; SIDE EFFECT REDUCTION, E.G. EXCESSIVE BLEEDING | GENENTECH, INC. (US) | 1997-09-02 | — | — | US | disclosed |
| US-5565449-A | PLATELET AGGREGATION INHIBITORS | GENENTECH, INC. (US) | 1996-10-15 | — | — | US | disclosed |
| EP-0610334-B1 | NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII B III A RECEPTOR | GENENTECH INC (US) | 1996-01-24 | — | — | EP | disclosed |
| EP-0610334-A1 | NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII b?III a? RECEPTOR. | GENENTECH INC (US) | 1994-08-17 | — | — | EP | disclosed |
| WO-1993008174-A1 | NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR | GENENTECH, INC. (US) | 1993-04-29 | — | — | WO | disclosed |